New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 5, 2014
16:23 EDTCYTXCytori Therapeutics places enrollment in ATHENA, ATHENA II trials on hold
Cytori Therapeutics has placed enrollment in the ATHENA and ATHENA II trials on clinical hold and therefore anticipates that it will not be possible to complete enrollment of the ATHENA I trial prior to the end of 2014 as previously anticipated. The decision to place the trials on hold was based on a safety review of reported cerebrovascular events. Symptoms occurred in three patients, of which two patients’ symptoms fully resolved within a short period of time and the third patient has had substantial resolution of symptoms. Such events had not been previously reported in Cytori’s other cardiovascular trials and appear to be related in part to the medical co-morbidities in the treated population and the complex nature of the procedures involved in the trial.
News For CYTX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 25, 2015
08:06 EDTCYTXCytori Therapeutics launches Celase GMP enzyme
Subscribe for More Information
March 23, 2015
08:03 EDTCYTXCytori Therapeutics presents thermal burn data at ABA meeting
Subscribe for More Information
March 18, 2015
07:41 EDTCYTXCytori amends pact to allow share sales under ATM facility immediately
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use